140 related articles for article (PubMed ID: 36788104)
21. Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases.
Frassica FJ; Unni KK; Beabout JW; Sim FH
J Bone Joint Surg Am; 1986 Oct; 68(8):1197-205. PubMed ID: 3021775
[TBL] [Abstract][Full Text] [Related]
22. Dedifferentiated peripheral chondrosarcomas. A report of seven cases.
Bertoni F; Present D; Bacchini P; Picci P; Pignatti G; Gherlinzoni F; Campanacci M
Cancer; 1989 May; 63(10):2054-9. PubMed ID: 2702574
[TBL] [Abstract][Full Text] [Related]
23. Dedifferentiation in bone and soft tissue sarcomas: How do we define it? What is prognostically relevant?
Dry SM
Hum Pathol; 2024 May; 147():139-147. PubMed ID: 38311185
[TBL] [Abstract][Full Text] [Related]
24. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
25. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
27. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
[TBL] [Abstract][Full Text] [Related]
28. Dedifferentiated chondrosarcoma of the rib with a malignant mesenchymomatous component: an autopsy case report.
Ishida T; Kuwada Y; Motoi N; Oka T; Machinami R
Pathol Int; 1997 Jun; 47(6):397-403. PubMed ID: 9211528
[TBL] [Abstract][Full Text] [Related]
29. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
31. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
33. Juxtacortical dedifferentiated chondrosarcoma from a primary periosteal chondrosarcoma.
Mitchell A; Rudan JR; Fenton PV
Mod Pathol; 1996 Mar; 9(3):279-83. PubMed ID: 8685228
[TBL] [Abstract][Full Text] [Related]
34. Dedifferentiation of low-grade chondrosarcomas.
Dahlin DC; Beabout JW
Cancer; 1971 Aug; 28(2):461-6. PubMed ID: 5566365
[No Abstract] [Full Text] [Related]
35. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
[TBL] [Abstract][Full Text] [Related]
36. Is the Width of a Surgical Margin Associated with the Outcome of Disease in Patients with Peripheral Chondrosarcoma of the Pelvis? A Multicenter Study.
Tsuda Y; Evans S; Stevenson JD; Parry M; Fujiwara T; Laitinen M; Outani H; Jeys L
Clin Orthop Relat Res; 2019 Nov; 477(11):2432-2440. PubMed ID: 31453886
[TBL] [Abstract][Full Text] [Related]
37. Dedifferentiated chondrosarcoma of bone.
Daly PJ; Sim FH; Wold LE
Orthopedics; 1989 May; 12(5):763-7. PubMed ID: 2657686
[TBL] [Abstract][Full Text] [Related]
38. Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.
Cao L; Wu Y; Han SM; Sun T; Yu BH; Gao F; Wu WJ; Gao BL
BMC Musculoskelet Disord; 2021 Feb; 22(1):189. PubMed ID: 33588810
[TBL] [Abstract][Full Text] [Related]
39. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
40. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
